27.13
-0.36(-1.31%)
Currency In USD
| Previous Close | 27.49 |
| Open | 27.15 |
| Day High | 28.17 |
| Day Low | 26.53 |
| 52-Week High | 29.51 |
| 52-Week Low | 1.87 |
| Volume | 3.57M |
| Average Volume | 3M |
| Market Cap | 2.44B |
| PE | -26.6 |
| EPS | -1.02 |
| Moving Average 50 Days | 14.88 |
| Moving Average 200 Days | 7.04 |
| Change | -0.36 |
If you invested $1000 in Terns Pharmaceuticals, Inc. (TERN) since IPO date, it would be worth $1,475.26 as of December 04, 2025 at a share price of $27.13. Whereas If you bought $1000 worth of Terns Pharmaceuticals, Inc. (TERN) shares 3 years ago, it would be worth $4,454.84 as of December 04, 2025 at a share price of $27.13.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
GlobeNewswire Inc.
Nov 14, 2025 9:05 PM GMT
FOSTER CITY, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that members of senior management will be presenting at the Jefferies G
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting
GlobeNewswire Inc.
Nov 03, 2025 2:05 PM GMT
Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient population Encouraging safety and tolerability profile at all doses evaluated Company to host investor update call on December 8th at 4:30pm ET FOSTE
Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity
GlobeNewswire Inc.
Oct 21, 2025 8:05 PM GMT
Results show maximum placebo-adjusted weight loss of 4.6% with 12% treatment discontinuation due to adverse events Asymptomatic, reversible grade 3 liver enzyme elevations occurred in three participants during post-treatment follow-up period, two of